that johnson & johnson teva mallinkrodt and teva on the source side. and distributors.he federal opened a criminal investigation into drug companies examining whether they violated that act which the "journal" points out is normally used to go after drug dealers. bernstein analyst rnie gao says he is surprised stocks movedlower. he says criminal investigations would be another thing. the report is that the probe is in the he remember stages but he also pointed out the stocks recovered a bit over the last month on potential expected relief in the lawsuit. some companies reaching a tentative settlement framework with states attorney general over the opioid litigation but not all states are onboard. and oxy continenten makes it's way through bankruptcy trying to get more state ag onboard contingent on the doj probes. a new york state case against multiple companies is scheduled to go t trial early nextear unless a settlement reached. deadline today just another reminder the saga is frar from far from over. more nieb, meg tyrell enchts best buyiring on all cylinders heading

there are reports teva and some of the other companies are in talks with the doj.y admit to some of it, may have to pay a fine, they cooperate with investigations but do not get indicted. that is key for teva because they continue to work with government programs like medicaid and the federal officials have an incentive. if you do file criminal charges that can bar them from working with medicaid and you take more competition out of the market and inadvertently raise prices, which is what they are trying to avoid. david: there are damages. there is civil law and the united states. if they are found guilty, there are legal problems they have. kailey: it is not just the criminal probe. they are facing a lawsuit from 48 states, and that is the civil allegation. even if they do settle with the doj, that could boost the civil case should they admit any wrongdoing. in regards to outside of generic drug pricing, you also have the opioid epidemic and are some potential liabilities with that. a lot of legal issues. david: but today is a good day for teva. kailey: so far. da

separately the ceo said today that the opioid rel aed litigatiinst teva could be resolved by the end. shares rose more than 4. to 8.47. holdings used to be called price line. reported better than expected earnings but came up shy on revenue. sharesere volatile in after hours trading. closing the regular session down more tn 8% to 18.49.93. >>> also after the bell. activa bonzzar posted results beating estimates thank to the launc of call of duty games. but they see the revenue in the holiday quarter below estimates due to increased competion from online and free to play games. shares were volatile after hours. enclose closing the regulation regular session down more than 3%. >>> gap's ceo art peck stepping down. the board's current non-executive chairman will take over the reins of the company for the time being. separately gap says comparable sales were down in the third quarter. gati shares ily fell sharply following the after hours news. they close the regular session up nearly 2% to 18.06. >>> and zillow's revenue topped expectations driven by the real estate website selling more

attorneys concerning the cbss act, the johnson & johnson, teva and drug company side and amer source bergen and mckesson of the distributors the "journal" recorded that the prosecutors opened the criminal investigation into drug companies. the "journal" reported it's normally used to go after drug dealers. bernie gou said he was surprised the stocks were moving charply slower criminal prosecutions would be another thing. he said the probe is it in the early stanls but buoyanted out the stocks recovered a quite a bit over the last month on potential expected relief in the lawsuits, particularly teva. some companies reached a tentative settlement framework over the litigation but not all states are onboard meanwhile purdue pharma continues through bankruptcy to go to get state ag's contingent on doj probes. and new york case against multiple companies is scheduled for trial early next year unless there is a the settlement. the another remind he were the saga is far from over for the companies. brian. >> meg tyrell, thank you very much. >> guys these are big names. the stocks hit today

teva pharmaceuticals and other generic drugmakers have held talks about resolving a u.s.rice missing and get -- fixing investigation. one of the possible outcomes with the justice department is a part -- deferred prosecution agreement. drugmakers would admit to certain allegations but would not be indicted. in return, they would pay fines and cooperate with investigations. that is your business flash update. let's turn to a bloomberg school . carl icahn is trying to seize control of occidental petroleum's or. icahn plans to nominate a slate of 10 direct or's. she has been a vocal critic of the company over its three $7 billion takeover of anadarko petroleum. joining us is the reporter who broke the deal, scott deveau. congratulations on this group. tell us what this would entail. carl icahn has tried in the past to put directors on the board, and that did not help out. what he was trying to do was solicit support from shareholders. this time around, it will be looking to replace the entire board at the annual general meeting. so what exactly is carl icahn so unhappy about

maduro would differ from that view of java's level yes but i don't where you just said about about teva marla's tell us what you think of this summit brick summit in brasilia what can we expect above the narrow of. the host is a good friend of washington i think that this is a pathetic reunion to have been a very important thing as the brinks of a with a deal there to deal with foreign biggest countries in book relation plus south africa and the tonight it to discuss and to share problems and big countries that are supposed to be independent autonomous parts of beijing in the world so society can do all of the. independent way and is a stroll in the bricks were created in brazil who had the rule not all of the thought in doors of brazil has a tradition or is a little all totally. foreign policy politics and it is changing to fully his balls are not also a matter of already the. spoils of very strongly his allegiance his commitment to his native state. manner that i may view is contradictory 'd is a deal of the brics but arguably the biggest cia base in the world the permanent one is in

guest: we have had a 50% increase in annual teva sits since beginning of the from club -- annual deficits since beginning of the trump administration. the striking thing is you do not have even a portion of republicans in congress criticizing the republican president for doing that. spending grew under president george w. bush. there were republicans unhappy with that who made that clear. under this president, we have not seen that. the republican party is not focused on that. part of it is the politics of the trump era. republican members especially in the house, who would have been most likely to complain about spending, have been the ones most loyal to president trump, whose voters seem to be most loyal to president trump. the president has not wanted to talk about this question. he is not interested in entitlement reform. you have not had even a portion of republicans in congress talking about this. i think it will be hard for them to get back to it under a democratic president without looking hypocritical. and being hypocritical. carl smith from bloomberg news writes about congressio

i'm the guy you guy can just claim to convince us yet and fact i might take a lesson from it wrong teva driver is now playing god i think ok. thanks. thank you thank you thank you thank you thank you thank you thank you thank you thank you i'm going to thank you yeah that is often if you sit in shot. oh i was trying not to step on the cord yeah they're not going to get a leg and we got to all those oh thank you to this of a kind of protest of modern gun can cope on such sites times i logged and just if you could come to some it's full been most that guy got into an office with us from the fire to how most unhappy of us because in the 12000000 follow out of you to all the food that you're used to afghanistan toolbag fewest you just a few that you call. yes so i have loved dancing since i was a kid i loved the violin and of dancing but my parents had me choose they couldn't afford both so they said do you want to play the violin or do you want to dance and i chose the violin but when i was 23 i decided it's not too late i'm going to teach myself how to dance and so i taught myself how to

stocks in drug manufacturers teva and amneal pharmaceuticals plummeted today.stributors amerisourcebergen and mckesson fell between 3% and 5%. the drug companies deny responsibility for the opioid crisis, saying they followed the laws and regulations that govern the pharmaceutical industry. now for our look at some of the newspaper and website stories which have caught our eye. joining me is tania jackson, managing director of red idea marketing agency. welcome. your first story, welcome. yourfirst story, mark zuckerberg discussed the future but only with mostly white men. yes, it seems appalling because if we talk about technology, there are so many people out there who could be able to do thatjob people out there who could be able to do that job and also women and diversity and we could see diversity on those nine persons, rarely. this isa on those nine persons, rarely. this is a story on bloomberg which talks about how mark zuckerberg completed his 2019 personal challenge on monday with this event where he says, i'm going to host a series of public discussio

teva and other companies are said to be in talks to end u.s.to a long-running criminal antitrust probe of alleged price-fixing by those companies. it looks like teva and its peers are in talks to end this probe. that stuck up almost 3% in premarket. we do want to give you an update on what is making headlines outside the business world. viviana hurtado is here with first world news. viviana: we begin with a compromise with china and the trade war with u.s.. on the raise penalties theft of intellectual property. the u.s. once china to commit to cracking down on ip theft. it also once the chinese to quit forcing american companies to hand over commercial secrets if they do want to do business there. president donald trump prepared to pour hundreds of millions of dollars next year in florida. the state is up for grabs because of changes in demographics and voting laws. democrats have made potential major inroads. republicans plan to make it expensive. plans to spend more than $200 million in florida. oracle's whiteboard attracting the scrutiny of

as a result, you can see names like teva, johnson & johnson, m mckess aeisa moving down. >>> we haveess than two minutes. stef, you bought freeport? >> it's only up 13%. i went to a conference last week, the management sounds great. they're entering technology into the systems, so i think there's positive operating to have if copper activity behaves. >> huge activity, massive at the ten strike, just massive huge. >> 20 seconds, josh, uber remains a top pick for 2020 at morgan stanley any thoughts there you had the london news this week >> knock yourself out. >> square, initiated outperform, price target is 105, better than a 50% possible up side >> wow >> not for me. >> paypal is better. joe owns paypal, you own paypal? >> i sold out and bought america express. >>> 45 seconds, finals stephanie, broadcom another lag guard, but it's a nice yield motor rolo solutions >> qsr, the impossible burger. i have a flight to catch. >> yeah, go. >> adi i talked about it, december 15s. >> remember what i told you about housing. calm down. >>> thank you, scott welcome to "the exchange." we have a b

co-loss sos with a phenomenal cancer immu immunotherapy franchise and something promising from op tevane reason it's been rallying hard let's take a look with giovanni, the ceo, to learn more about what the future holes for his combined company welcome back to "mad money." good to see you, giovanni. first, congratulations just a remarkable achievement by you. a lot felt i don't know if it could be done. give us what the new bristol-myers looks like >> well, thanks for having me. it's a great time for us, really important moment the new bristol-myers squib is a leading bio farm father company that can transform the lives of more patients through science. we have the number one cancer company in the world and leading franchises in cardiovascular medicines and a lot of things have happened that are good and every franchise we have leading blands, growing businesses and working on seven new medicines to launch. you may remember when we last got together, i mentioned six launch. >> yes. >> where two medicines have been approved by the fda and a seventh one had positive data. we're getting r

. >> i don't really have a lot good to say about teva. there are so many unbelievable pharmaceutical companies to choose from, so many good ones. go by some advi. why don't we go to matt and my daughter's old home state of oregon. matt. >> i got a question on roku in my growth stock portfolio. >> right. >> my daughter-in-law got me involved in the stock this spring and worked out extremely well. then this fall with the so-called value rotation got all of these stocks knocked down. so i added two it in here. it maintained a 50% revenue growth, which is unbelievable, and hardware is on virtually, you know, the majority of tv brands. >> right. >> i know there's a secondary coming. and the shorts seem to be feeding media stories almost every week. but i'm up about 25% adding a stock from about 6% on the high. >> let's not be greedy. this stock support remarkable. it's up a remarkable amount. the one thing i would tell you about roku, any time there's good news of streaming service like that, roku catches fire. you do need to have a constant s

"wall street journal" reports that fed are looking at johnson & johnson, teva, amerisourcebergen and mckesson. the probe, we'll see if the companies intestingly allowed opioids to flood communities using laws typically used to put drug dealers in jail folks. this could be criminal. shares of all six companies taking a hit on that news. >>> coming up i will talk with herman cain what he thinks about the democratic field. candidates, ones dominating are all 70 years or older. talking about the young, woke, diverse democratic party. a shoe company calling out amazon for mimicking its 95-dollar wool sneaker. is it smart capitalism or insatiable greed. >>> elon musk is accepting ultimate rematch between the cyber truck and ford f-150. when will we see the rematch everyone is hoping for? my money on the f-150. we'll be right back. imagine traveling hassle-free with your golf clubs. now you can, with shipsticks.com! no more lugging your clubs through the airport or risk having your clubs lost or damaged by the airlines. sending your own clubs ahead with shipsticks.com makes it fast & easy t

the drugmakers include amneal, mallinckrodt and teva, along with distributors amerisource-es bergen and mn. on wall street today, the dow jones industrial average gainedo 42 points to at 28,164. the nasdaqose 57 points, and the s&p 500 added 13. former president jimmy carter was released from a hospital in atlanta today, to head home for thanksgiving. he had surgery two weeks ago t relieve pressure on his brain, caused by bleeding from a recent fall. mr. carter is 95 years old. and, former deputy attorney general william ruckelshaus has died. he gained fame in 1973 when he refused to fire the watergate special prosecutor, as predent nixon had ordered, and resigned instead. he was also the first head of the environmental protection auency. william ruckelshwas 87 years old. still to come on the newshour: the white house's pressure on ukraine grows clearer and we check in to see how impeachment is resonating around the country.os hidden of two-day shipping. the dangerous conditions facedre by amazon's wause workers. reversing mammoth amounts of food waste in southern california, and much m

about 300,000 shares premarket volume it's a bit of a mixed report for teva we have earnings missingaise its full year outlook slightly it was helped along by product launches in key markets in north america. we'll watch the shares, jumpy premarket. >>> profits and revenues here, both beat estimates for the drug distributor after adjusting for costs related to the opioid lawsuit settlements. they were one of the companies that decided to settle the opioid settlement litigation we'll see if the stock moves on the up side. seaworld is down 3%. roughly 1200 shares premarket volume profits and sales both missed estimates. they blame among other things, bad weather at park locations in florida. sergio rivera will be named the permanent c.e.o. effective next month. melissa, those stocks two green, one red. i'll send it back over to you. >> thank you see you later. >>> moving markets, china bringing in principal to bring existing tariffs we'll talk saudi arabia and twitter. lots to cover when we return >> announcer: don't forget to subscribe to our podcast you'll get interviews, original co

mylan and teva on there as well. they're often old and cheaply price yet complex to manufacture.manufacturing issue or a company drops out of the market, supply can get squeezed we asked merck's ceo about ceg in june. >> it will be a problem that will continue to be for us going forward. when the prices of drugs get too low, specifically generic drugs, you don't have the market incentive for people to put up the facilities. >> why not raise the price of the drug they said it wouldn't be the responsible thing to do. >> meg, this story is starting great reporting all day on cnbc today. i'm curious how this will factor in, or if it is factors in at all to the conversations we're seeing in d.c., the administration or candidates around drug pricing more broadly. >> great point, morgan so much of the conversation has been around high drug prices this is often a result of drug prices being too low and not an appealing market for drug companies to get into. we've seen legislation introduced by susan collins and others focused on this issue fda has formed a task force around it. there's m

major avenues are on pace for their strongly monthly gains since june shares of teva holding talks of alleged price fixing prosecutors have been investigating whether they and other generic drug makers conspired to increase prices for certain medications. you can see shares trading higher by more than 4% despite or perhaps because of a rocky unveiling of the cyber truck, elon musk says he's received more than 200,000 orders you must pay a $100 preorder fee. shares of tesla are trading up that car is too strange for words in my personal opinion as a non truck owner. >> a lot of us agree but clearly hundreds of thousands of people don't. >> $100 though and you get it refunded >> you can tell all your friends i put $100 on one of those cyber trucks. >> i've never seen a funnier clip though. >> yes. >> unbelievable. let's get over to mike santoli for today's market dashboard. >> let's run through what we have today first of all, wedding cashers, companies coming together in matrimony often in exchange for cash will put some numbers on the merger deals waking in seattle perhaps getting rev

obviously with some of, we're looking at some big companies, teva, j&j, others on the screen right now the cases and marketing practices and the like. as a prosecutor, when you look over some cases, do the prosecutors have a good argument against the companies i guess to ask it simply? >> sure. so it is a little bit difficult to make cases against these companies who are not directly committing criminal acts but the companies are held to certain standards to report suspicious orders, report companies making orders for non-medical purposes. if prosecutors show there was intentional or reckless disregard for what these drugs were being used for and for illegitimate purposes, then i think they can get to the point of proving a criminal case. obviously a lot more to it than that. they have to show there is intentional act, or reckless disregard, that results in the death or serious injury for somebody. that will be key. connell: there is a example in "the wall street journal" the company is called the rochester drug cooperative. that is in the article we referenced today. the company is sa

guest: we have had a 50% increase in annual teva sits since beginning of the from club -- annual deficitsince beginning of the trump administration. the striking thing is you do not have even a portion of republicans in congress criticizing the republican president for doing that. spending grew under president george w. bush. there were republicans unhappy with that who made that clear. under this president, we have not seen that. the republican party is not focused on that. part of it is the politics of the trump era. republican members especially in the house, who would have been most likely to complain about spending, have been the ones most loyal to president trump, whose voters seem to be most loyal to president trump. the president has not wanted to talk about this question. he is not interested in entitlement reform. you have not had even a portion of republicans in congress talking about this. i think it will be hard for them to get back to it under a democratic president without looking hypocritical. and being hypocritical. carl smith from bloomberg news writes about congressiona

teva. these are some big, big operations. operations. >> names we all know.t, they have now cast this and that pretty mouth as wide as i can go. not just the back alley. now going after that manufacturers of these opioids to determine whether or not they are fully complying with the controlled substances act and how that is contributing to a crisis. it is a crisis. i know you have people on one side to say i can't live, i need to manage my pain. then people on the other side who have managed to find their way and because of this crisis. this is something that i think needs to happen. >> jon: there is an element of personal responsibility. it is not all the drug companies fault, right? >> now, but are that but really aggressively these drugs? how does it happen that you can get a prescription, which could be to manage your pain, and then i have an does you get legit prescription, it gets cut off, but your addiction does not. so then what happens to that person? they go on the street, and then people are dying in droves. 400,000 americans in the last 20 years h

business is how do you want to price that growth not what is the growth of the business and use the tevain the era where there's been a slower number of generics coming to market. what that does, that's the single highest margin that walgreens sell in the back of the store, 38% margins that's the biggest margin thing. we have fewer generics or less new drugs to role to generic off patten >> this is totally outside his wheel house. why would he buy a drugstore that's not something he's been involved in in the past. health care stocks aren't something he's been involved in in the past. do you know anything or are you just kind of speculating because you look at it >> no, i'm saying the kind of business, the kind of profile, he'd be a white knight to step on this like kkr people are making the same case why is buffet buying oxy that's not one of his kind of businesses but price and what he thinks he's getting for that is playing into -- i would not be shocked in oxy's case -- >> he didn't buy it on open market >> they bought $300 million worth. >> in the latest filings that they showed but